Response Biomedical Receives Chinese Clearance for Ramp 200

The approval from SFDA will help the company increase its market presence in China where the IVD market is estimated at $2 billion per year.

Full-text access for registered users only. Existing users login here.
New to GenomeWeb? Register here quickly for free access.

Related Stories